PillRx only · Injection · Intramuscular
Fulvestrant
Brands: Cligavyx · Faslodex · Fulvestrant
9 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US12 NDCs
9 active makers
9 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
1.8K
Rx · 2026 Q1
16K
Units dispensed
-52%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it9 active · 1 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| BluePoint Laboratories | unknown | 2 | SUPPLYING |
| Sandoz Inc | unknown | 2 | SUPPLYING |
| AstraZeneca Pharmaceuticals LP | unknown | 1 | SUPPLYING |
| Accord Healthcare Inc. | unknown | 1 | SUPPLYING |
| Alembic Pharmaceuticals Limited | unknown | 1 | SUPPLYING |
| Glenmark Pharmaceuticals Inc., USA | unknown | 1 | SUPPLYING |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | unknown | 1 | SUPPLYING |
| Avyxa Pharma, LLC | unknown | 1 | SUPPLYING |
| Hikma Pharmaceuticals USA Inc. | unknown | 1 | SUPPLYING |
| Meitheal Pharmaceuticals Inc. | unknown | 1 | EXITED 2027 |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Aug 27, 2021RECALLRecall (Class II): Fulvestrant Injection 250 mg/5 mL (50 mg/mL) For Intramuscular Use Only Contains 2 single-dose pre-filled syringes Rx o…
Lack of Assurance of Sterility — Recalling firm: Glenmark Pharmaceuticals Inc., USA — Nationwide.